Saba NF, Chaudhary R, Kirtane K, Marra A, et al. Pembrolizumab and cabozantinib in recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSCC): long-term survival update with a biomarker analysis. Clin Cancer Res 2024 Aug 21. doi: 10.1158/1078-0432.CCR-24-1202.
PMID: 39167623